FDA-Aware Kendall Square Life Sciences Content
For Cambridge CROs, CDMOs, and pharmaceutical technology vendors. FDA promotional compliance review for every content piece before publication. Phase I-IV clinical research content with appropriate methodology disclosure. CLIA/CAP/ISO 15189 certification content. Harvard Medical School research collaboration content. Dana-Farber clinical trial affiliation content. Stat News, FiercePharma, and BioPharma Dive editorial placement programme. The pharmaceutical content library that earns genuine credibility from Boston's FDA-sophisticated pharma procurement community — without creating promotional compliance exposure.
